Mersana Therapeutics
MRSN
MRSN
126 hedge funds and large institutions have $366M invested in Mersana Therapeutics in 2022 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 50 increasing their positions, 36 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.24% less ownership
Funds ownership: 3.88% → 3.64% (-0.24%)
2% less funds holding
Funds holding: 128 → 126 (-2)
93% less call options, than puts
Call options by funds: $19K | Put options by funds: $257K
Holders
126
Holding in Top 10
2
Calls
$19K
Puts
$257K
Top Buyers
| 1 | +$14.6M | |
| 2 | +$9.89M | |
| 3 | +$6M | |
| 4 |
BlackRock
New York
|
+$5.8M |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$3.93M |
Top Sellers
| 1 | -$4.21M | |
| 2 | -$3.81M | |
| 3 | -$3.18M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$2.89M |
| 5 |
Morgan Stanley
New York
|
-$2.76M |